Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantation

References

• Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. 2009. Defining the intensity of conditioning regimens:working definitions. Biology of Blood and Marrow Transplantation 15:1628–1633.
   PubMed Web of Science ®Google Scholar
• Balashov DN, Papusha LI, Nazarenko TA, Trakhtman PE, Revishvili NA, Maschan AA, et al. 2011. Recovery of ovarian function and pregnancy in a patient with AML after myeloablative busulphan-based conditioning regimen. Journal of Pediatric Hematalogy Oncology 33:154155
   Web of Science ®Google Scholar
• Bath LE, Critchley HOD, Chambers SE, Anderson RA, Kelnar CJH, Wallace WHB. 1999. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. British Journal of Obstetrics and Gynaecology106:1265–1272.
   PubMedGoogle Scholar
• Boldrini R, Di Cesare M, Tamburini C. 2012. Certificato di assistenza al parto (CeDAP) Analisi dell’evento nascita anno 2009. Available from: http://www.salute.gov.it.
   Google Scholar
• Chiodi S, Spinelli S, Ravera G, Petti AR, VanLint MT, Lamparelli T, et al. 2000. Quality of life in 244 of allogeneic bone marrow transplantation. British Journal of Hematology 11:614–619.
   Web of Science ®Google Scholar
• Critchley HOD, Bath LE, Wallace WHB. 2002. Radiation damage to the uterus - review of the effects of treatment of childhood cancer. effects treatment childhood. Hum Fertil (Camb) Fertility 5:61–66.
   PubMedGoogle Scholar
• Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, et al. 2005. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. International Journal of Radiation Oncology Biology Physics 63:1568–1575.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. 2005. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group. Biology of Blood and Marrow Transplantation 11:945–955.
   PubMed Web of Science ®Google Scholar
• Grigg AP, McLachlan R, Zajac J, Szer J. 2000. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg) bone marrow. Transplantation 26:1089–1095.
   Web of Science ®Google Scholar
• Jadoul P, Anckaert E, Dewandeleer A, Steffens M, Dolmans MM, Vermylen C, et al. 2011. Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence. Fertility and Sterility 96:126–133.
   PubMed Web of Science ®Google Scholar
• Langan RC, Prieto PA, Sherry RM, Zlott D, Wunderlich J, Csako G, et al. 2011. Assessment of Ovarian Function after preparative chemotherapy and total body radiation for adoptive cell therapy. Preparative and Body for Cell. Journal of Immunotherapy 34:397–402.
   PubMed Web of Science ®Google Scholar
• Lunsford AJ, Whelan K, McCormick K, McLaren JF. 2014. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors. Fertility Sterility 101:227–231.
   PubMed Web of Science ®Google Scholar
• Matias K, Matias C, Texeira H Freire AD, Azevedo A. 2008. Successful pregnancy following busulfan and cyclophosphamide conditioning and allogeneic bone marrow transplantation for chronic myeloid leukaemia. Biology of Blood and Marrow Transplantation 14:944–945.
   PubMed Web of Science ®Google Scholar
• Porcu E, Venturoli S, Fabbri R, Orsini LF, Sganga E, Brondelli L, et al. 1989. Uterine development and endocrine relationships after menarche. American Journal of Obstetrics and Gynecology 161:174–177.
   PubMed Web of Science ®Google Scholar
• Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, et al. 2013. Ongoing graft versus host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation. A survey of the late effect working party of the European Group for Blood and Marrow Transplantation. Haematologica 98:339–345.
   Google Scholar
• Salooja N, Szydio RM, Sociè G, Rio B, Chatterjee R, Ljungman P, et al. 2001. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358:271–276.
   PubMed Web of Science ®Google Scholar
• Sanders JE, Buckner CD, Leonard JM, Sullivan KM, Witherspoon RP, Deeg HJ, et al. 1983. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 36:252–255.
   PubMed Web of Science ®Google Scholar
• Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, et al. 1988. Ovarian function following marrow transplantation for aplastic anemia or leukemia. Journal of Clinical Oncology 5:813–818.
   Google Scholar
• Sanders JE, Howley J, Lewy W, Gooley T, Buckner CD, Deeg HJ, et al. 1996. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87:3045–3052.
   PubMed Web of Science ®Google Scholar
• Spinelli S, Chiodi S, Bacigalupo A, Brasca A, Menada MV, Petti AR, et al. 1994. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. marrow: Bone Marrow Transplantation 14:373–380.
   PubMed Web of Science ®Google Scholar
• Wallace WHB, Thomson AB, Saran F, Kelsey T. 2005. Predicting age of ovarian failure after radiation to a field that includes the ovaries. International Journal of Radiation Oncology Biology Physics 62:738–744.
   PubMed Web of Science ®Google Scholar